awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38544841-9C36667B-B41B-4A6A-98FB-7DB2075B6769
Q38544841-9C36667B-B41B-4A6A-98FB-7DB2075B6769
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38544841-9C36667B-B41B-4A6A-98FB-7DB2075B6769
Sorafenib: 10 years after the first pivotal trial.
P2860
Q38544841-9C36667B-B41B-4A6A-98FB-7DB2075B6769
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38544841-9C36667B-B41B-4A6A-98FB-7DB2075B6769
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
17dcdb329a831799a7195fe7c1641792bd7c488a
P2860
Sorafenib in locally advanced or metastatic breast cancer.